ASEAN’s Leading Radiopharmaceutical Company

Making Radiopharmaceuticals Accessible

Cyclotek partners with researchers, healthcare providers and pharmaceutical organisations to develop, manufacture and deliver the radiopharmaceuticals and radioactive medical devices that enable precision diagnosis, treatment and advance the future of patient care across Australia, New Zealand and ASEAN.

About Us

Trusted Infrastructure. Proven Capability.

Supporting hospitals, clinics, researchers and pharmaceutical partners with reliable radiopharmaceutical and radioactive medical device manufacturing, supply and scientific expertise across ASEAN.

6 TGA & GMP Licensed Facilities Across ANZ

Trusted Supply Network Supporting 200,000+ Patients Annually

Clinical, Research & CDMO Capabilities

Long-Term Partnerships Across Healthcare, Research & Industry

About Us

Built on Precision.
Positioned for What’s Next.

Cyclotek is ASEAN’s leading radiopharmaceutical CDMO, manufacturing and supplying the radiopharmaceuticals and radioactive medical devices that healthcare providers and researchers rely on every day to support precision diagnosis and patient care.

For more than 25 years, Cyclotek has combined scientific expertise, operational precision and trusted infrastructure to support hospitals, clinics, research institutions and pharmaceutical partners across Australia and New Zealand.

Today, Cyclotek is helping shape the next phase of radiopharmaceutical innovation through clinical trial support, CDMO partnerships, advanced manufacturing capability and strategic research collaborations across ASEAN.

Our experienced team works in collaboration with hospitals, researchers and industry partners to deliver innovative radiopharmaceutical solutions that improve diagnosis, treatment and patient outcomes.

25+

Trusted for Over 25 Years

Radiopharmaceutical Products & Scientific Services

Integrated manufacturing, supply and research capabilities supporting clinical care, research translation and the future of precision medicine.

PET Radiopharmaceuticals

A range of clinical, research and proprietary PET tracers.

Learn More

Product Supply & Logistics

Reliable radiopharmaceutical manufacturing and supply supporting clinical imaging and patient care across Australia and New Zealand.

Learn More

Contract Manufacturing

Advanced TGA and GMP licensed manufacturing facilities supporting commercial production, research and clinical trial supply.

Learn More

Our Facilities

Infrastructure Built for Precision & Reliability

Melbourne - Bundoora

This facility was established in 2002 to produce FDG for the Australian marketplace. Over the years, Cyclotek has developed and implemented systems to undertake Technology Transfer of new tracers and now routinely manufactures 12 tracers.

Melbourne - Parkville

This facility is situated at the new Victorian Comprehensive Cancer Centre (new home of Peter MacCallum Cancer Centre) in the Parkville precinct. Peter MacCallum is Australia’s only dedicated cancer hospital and research facility.

Sydney - Lucas Heights

Located in the heart of the Australian Nuclear Science & Technology Organisation’s (ANSTO) Lucas Heights campus, this facility was established in 2009 with twin Siemens Eclipse cyclotrons. Operated by Cyclotek, the facilities services the PET imaging providers within New South Wales.

Sydney - Macquarie University

Established by Cyclopharm Ltd in 2010, this facility is located at the Macquarie University Hopital, within the Macquarie Park. Designed to enable routine production of radiopahrmaceuticals and radioactive medical devices.

Wellington - New Zealand

This facility was established in 2010 as a joint venture between Cyclotek (Aust) Pty Ltd and Pacific Radiology Group Limited. Cyclotek Wellington supplies multiple radiopharmaceutical products throughout the region.

Brisbane - Woolloongabba

This facility was established in early 2016 within the Princess Alexandra Hospital precinct in Woolloongabba. Princess Alexandra Hospital is one of three tertiary level facilities in Queensland, providing care in all major adult specialties, with the exception of obstetrics.

Corporate - Head Office

Cyclotek's Head Office supports the strategic, commercial and financial functions that sit behind the company's radiopharmaceutical manufacturing network. From this base, Cyclotek coordinates customer engagement, business development, innovation and group-wide support for facilities across Australia, New Zealand and ASEAN.

Partnership & Research

Partnerships Driving Innovation & Access

Cyclotek works alongside pharmaceutical companies, healthcare providers, universities and research institutions to support the development and delivery of next-generation radiopharmaceuticals and radioactive medical devices. From early-stage research and first-in-human studies through to commercial manufacturing and regional supply, Cyclotek provides the infrastructure, scientific capability and operational expertise required to bring innovation closer to patients.

Partner with Cyclotek

Whether you are exploring clinical trial supply, CDMO capability, research collaboration or regional market access, Cyclotek’s team can help support the next stage of your program across Australia, New Zealand and ASEAN Leaders in the development, manufacturing and supply of Radiopharmaceuticals and radioactive medical devices across Australia, New Zealand, & ASEAN.